Business Context and Reporting Period
This Form 6-K filing by Gauzy Ltd. covers the month of February 2026. The report addresses a regulatory deficiency notice received from The Nasdaq Stock Market regarding corporate governance compliance.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a listing compliance issue and contains no financial performance data.
Material Changes
The primary material event is the receipt of a Nasdaq Deficiency Letter on February 3, 2026. The Company is currently non-compliant with Nasdaq Listing Rules 5605(b)(1), 5605(c)(2), and 5605(d)(2) concerning board and committee independence.
Outlook, Risks, and Management Commentary
- Compliance Deadline: Gauzy has 45 calendar days (until March 20, 2026) to appoint sufficient independent director candidates or submit a compliance plan to Nasdaq.
- Extension Possibility: If a plan is accepted, Nasdaq may grant an extension of up to 180 calendar days to achieve compliance.
- Delisting Risk: If the Company fails to submit an acceptable plan, its securities may be subject to delisting. The Company retains the right to appeal to an independent hearings panel, though success is not assured.
- Management Action: The Company states it is actively identifying and evaluating qualified independent director candidates to regain compliance.
Key Facts for Investor Verification
- Verify the current composition of the Board of Directors to assess the gap in independent director requirements.
- Monitor the Company's progress in appointing new independent directors before the March 20, 2026 deadline.
- Review the attached press release (Exhibit 99.1) for any additional details on the specific governance deficiencies.
- Assess the risk of potential delisting if the Company fails to meet Nasdaq's listing standards within the allotted timeframe.